These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12926652)

  • 21. Prevention and management of osteoporosis.
    World Health Organ Tech Rep Ser; 2003; 921():1-164, back cover. PubMed ID: 15293701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct and indirect costs of arthritis and other rheumatic conditions--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Nov; 52(46):1124-7. PubMed ID: 14627951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to measure the impact of musculoskeletal conditions.
    Woolf AD; Vos T; March L
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):723-32. PubMed ID: 21665121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
    Odegaard K; Borg S; Persson U; Svensson M
    Int J Pediatr Obes; 2008; 3 Suppl 1():51-7. PubMed ID: 18278633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Musculoskeletal medicine--strategies towards a "good musculoskeletal consultation"].
    Vulfsons S
    Harefuah; 2011 Mar; 150(3):237-9, 305, 304. PubMed ID: 21574355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Musculoskeletal conditions in France.
    Euller-Ziegler L
    J Rheumatol Suppl; 2003 Aug; 67():42-4. PubMed ID: 12926653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost estimates of brain disorders in Belgium.
    Schoenen J; Gianni F; Schretlen L; Sobocki P
    Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health planning in rheumatic diseases. Elaboration of a master plan for rheumatic and musculoskeletal diseases of Catalonia.
    Larrosa M; Surís X; Pueyo MJ; Auleda J; de la Puente ML
    Reumatol Clin; 2012; 8(2):72-7. PubMed ID: 22341527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
    Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
    Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoporosis: a still increasing prevalence.
    Reginster JY; Burlet N
    Bone; 2006 Feb; 38(2 Suppl 1):S4-9. PubMed ID: 16455317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meeting increased demand.
    Blair A
    Jpn Hosp; 2004 Jul; (23):19-22. PubMed ID: 19195249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost analysis of osteoporotic hip fractures.
    Woratanarat P; Wajanavisit W; Lertbusayanukul C; Loahacharoensombat W; Ongphiphatanakul B
    J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S96-104. PubMed ID: 16869109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of rheumatoid arthritis and access to treatment: health burden and costs.
    Lundkvist J; Kastäng F; Kobelt G
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S49-60. PubMed ID: 18157732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What are the costs of childhood-onset rheumatic disease?
    Minden K
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):223-40. PubMed ID: 16546054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.